Characterization of fibroblast growth factor receptor 1 in small-cell lung cancer

Journal of Thoracic Oncology

Volumn 9, Issue 4, 2014, Pages 567-571

  Thomas, Anish ^a   Lee, Jih Hsiang ^a   Abdullaev, Zied ^a   Park, Kang Seo ^a   Pineda, Marbin ^a   Saidkhodjaeva, Lola ^a   Miettinen, Markku ^a   Wang, Yisong ^a   Pack, Svetlana D ^a   Giaccone, Giuseppe ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Copy number gain; FGFR1; Focal amplification; Small cell lung cancer

Indexed keywords

1 TERT BUTYL 3 [6 (3,5 DIMETHOXYPHENYL) 2 (4 DIETHYLAMINOBUTYLAMINO)PYRIDO[2,3 D]PYRIMIDIN 7 YL]UREA; CISPLATIN; ETOPOSIDE; FIBROBLAST GROWTH FACTOR RECEPTOR 1; GENOMIC DNA; MESSENGER RNA; FGFR1 PROTEIN, HUMAN; PYRIMIDINE DERIVATIVE;

ARTICLE; CHEMOSENSITIVITY; CHROMOSOME; COMPARATIVE GENOMIC HYBRIDIZATION; COPY NUMBER VARIATION; CYTOGENETICS; DRUG SENSITIVITY; GENE AMPLIFICATION; GENE DOSAGE; GENE MUTATION; GROWTH INHIBITION; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENSITIVITY ANALYSIS; SMALL CELL LUNG CANCER; CELL PROLIFERATION; CHROMOSOME 8; DRUG RESISTANCE; FLUORESCENCE IN SITU HYBRIDIZATION; GENETICS; LUNG NEOPLASMS; METABOLISM; MUTATION; PROGNOSIS; REAL TIME POLYMERASE CHAIN REACTION; SMALL CELL LUNG CARCINOMA; TISSUE MICROARRAY; TUMOR CELL CULTURE; WESTERN BLOTTING;

BLOTTING, WESTERN; CELL PROLIFERATION; CHROMOSOMES, HUMAN, PAIR 8; COMPARATIVE GENOMIC HYBRIDIZATION; DRUG RESISTANCE, NEOPLASM; GENE AMPLIFICATION; GENE DOSAGE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LUNG NEOPLASMS; MUTATION; PROGNOSIS; PYRIMIDINES; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 1; SMALL CELL LUNG CARCINOMA; TISSUE ARRAY ANALYSIS; TUMOR CELLS, CULTURED;

EID: 84919717017     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0000000000000089     Document Type: Article

References (12)

1. Van Meerbeeck JP, Fennell DA, De Ruysscher DK. Small-cell lung cancer. Lancet 2011; 378: 1741-1755.
2. Oze I, Hotta K, Kiura K, et al. Twenty-seven years of phase III trials for patients with extensive disease small-cell lung cancer: disappointing results. PLoS One 2009; 4: e7835.
3. Rudin CM, Durinck S, Stawiski EW, et al. Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer. Nat Genet 2012; 44: 1111-1116.
4. Peifer M, Fernández-Cuesta L, Sos ML, et al. Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer. Nat Genet 2012; 44: 1104-1110.
5. Voortman J, Lee JH, Killian JK, et al. Array comparative genomic hybridization- based characterization of genetic alterations in pulmonary neuroendocrine tumors. Proc Natl Acad Sci U S A 2010; 107: 13040-13045.
6. Turner N, Grose R. Fibroblast growth factor signalling: from development to cancer. Nat Rev Cancer 2010; 10: 116-129.
7. Weiss J, Sos ML, Seidel D, et al. Frequent and focal FGFR1 amplification associates with therapeutically tractable FGFR1 dependency in squamous cell lung cancer. Sci Transl Med 2010; 2: 62ra93.
8. Pardo OE, Latigo J, Jeffery RE, et al. The fibroblast growth factor receptor inhibitor PD173074 blocks small cell lung cancer growth in vitro and in vivo. Cancer Res 2009; 69: 8645-8651.
9. Lee JH, Voortman J, Dingemans AM, et al. MicroRNA expression and clinical outcome of small cell lung cancer. PLoS One 2011; 6: e21300.
10. Pack SD, Zhuang Z. Fluorescence in situ hybridization: application in cancer research and clinical diagnostics. Methods Mol Med 2001; 50: 35-50.
11. Pleasance ED, Stephens PJ, O'Meara S, et al. A small-cell lung cancer genome with complex signatures of tobacco exposure. Nature 2010; 463: 184-190.
12. Hammerman PS, Lawrence MS, Voet D, et al. Comprehensive genomic characterization of squamous cell lung cancers. Nature 2012; 489: 519-525.